natgillin/translations-raw huggingface dataset:
trembling, sweating, pale looking a change in mood or feeling anxious or confused.
tresenje, znojenje, bledica sprememba razpoloženja ali občutek tesnobe ali zmedenosti
tremor
drhtavica
Tremor
drhtenje
tremor
tresavica
tremor
tresenje
tremor
tresenje (tremor)
Tremor (minor shaking)
drhtavica (blago tresenje)
tremor (shaking)
tremor (tresavica)
tremor (shaking)
tremor (tresenje)
tremor (shaking) dystonia: slow or sustained involuntary contraction of muscles.
tremor (tresenje) distonija: nehoteno počasno ali dolgotrajno krčenje mišic.
tremor (shaking) flushing
tremor (tresenje) zardevanje
tremor (to tremble)
tremor (tresenje)
tremor anxiety
tresavica, tesnoba.
Tremor Disturbance in attention Dysgueusia Syncope
tremor motnje pozornosti motnje v okušanju sinkopa
Tremor Dizziness Somnolence Headache
tremor vrtoglavost somnolenca glavobol
Tremor Headache
drhtenje glavobol
Tremor Headache Dizziness Asthenia
tremor glavobol omotičnost astenija
Tremor Headache Dizziness Fatigue
tremor glavobol omotičnost utrujenost
Tremor of the head or a limb which increases when trying to perform a particular function (intention tremor)
tremor glave ali okončine, ki se okrepi, kadar poskušate narediti kako dejanje (intencijski tremor);
tremor or numbness, including numbness or tingling of the skin
tresenje ali otrplost, vključno z otrplostjo ali mravljinčasto kožo
tremor taste disturbance.
tresavica, motnje okušanja.
Tremor Vertigo Dizziness
tremor vrtoglavica omotica
Tremor, dysgeusia, syncope, hypoesthesia, paraesthesia
tremor, disgevzija, sinkopa, hipestezija, parestezija
Tremor, lethargy, loss of consciousness, balance disorders, dysgeusia
tremor, letargija, izguba zavesti, motnje ravnotežja, dizgevzija
tremor, muscle spasms, convulsions feeling anxious or depressed, changes in your mood or thoughts.
tremor, mišični krči, konvulzije, občutek strahu ali depresija, spremembe v razpoloženju ali načinu mišljenja.
tremor, muscle spasms, convulsions, feeling anxious or depressed, changes in your mood or thoughts.
tremor, mišični krči, konvulzije, občutek strahu ali depresija, spremembe v razpoloženju ali načinu mišljenja.
tremor, muscle spasms, convulsions, feeling depressed, changes in your mood or thoughts.
tremor, mišični krči, konvulzije, depresija, spremembe v razpoloženju ali načinu mišljenja.
Tremor, Neuralgia, Hypersensitivity reaction, Hypoaesthesia
preobčutljivostne reakcije, hipestezija
tremor, paraesthesia, cerebrovascular accident, dizziness, syncope, lethargy, neuropathy peripheral
tremor, parestezija, možganska kap, omotica, sinkopa, letargija, periferna nevropatija
Tremor, paresthesia, hypoesthesia, migraine, flushing,
tremor, parestezije, hipoestezija, migrena, pordelost,
Tremor, paresthesia, hypoesthesia, migraine, flushing,
tremor, parestezije, hipoestezija, migrena, zardevanje,
Tremor, Peripheral sensorimotor neuropathy, Dyskinesia*, Cerebellar coordination and balance disturbances*, Memory loss (exc dementia)*, Encephalopathy*, Posterior Reversible Encephalopathy Syndrome#, Neurotoxicity, Seizure disorders*, Post herpetic neuralgia, Speech disorder*, Restless legs syndrome, Migraine, Sciatica, Disturbance in attention, Reflexes abnormal*, Parosmia
tremor, periferna motorična nevropatija, diskinezija*, motnje koordinacije in ravnotežja v malih možganih*, izguba spomina (brez demence)*, encefalopatija*, posteriorna reverzibilna encefalopatija*, nevrotoksičnost, motnje s krči*, postherpetična nevralgija, motnje
Tremor, Peripheral sensorimotor neuropathy, Dyskinesia*, Cerebellar coordination and balance disturbances*, Memory loss (exc dementia)*, Encephalopathy*, Posterior Reversible Encephalopathy Syndrome#, Neurotoxicity, Seizure disorders*, Post herpetic neuralgia, Speech disorder*, Restless legs syndrome, Migraine, Sciatica, Disturbance in attention, Reflexes abnormal*, Parosmia
tremor, periferna motorična nevropatija, diskinezija*, motnje koordinacije in ravnotežja v malih možganih*, izguba spomina (brez demence)*, encefalopatija*, posteriorna, reverzibilna encefalopatija*, nevrotoksičnost, motnje s krči*, post-herpetična nevralgija, motnje govora*, sindrom nemirnih nog, migrena, išias, motnje pozornosti, nenormalni refleksi*, parozmija
tremor, skin discolouration.
tresenje, obarvanje kože.
Tremor.
tremor
Tremor.
tresenje,
tremor/shaking, increased sensitivity to stimuli
tremor/tresavica, povečana občutljivost na dražljaje;
tremor;
tresavica;
tremor;
tresenje;
Tremoram, dysgeusiaam, syncopeam, hypoesthesiaam, paraesthesiaam
tremoram, disgevzijaam, sinkopaam, hipestezijaam, parestezijaam
tremors (shakiness, often in the hands)
tremor (tresenje, pogosto tresenje rok),
tremors, convulsions abnormality of electrocardiogram (ECG), called prolongation of QT interval
tremor, konvulzije nepravilnosti v elektrokardiogramu (EKG), t. i. podaljšanje intervala QT,
tremors; sudden jerking of muscles (myoclonus)
tresenje, nenadno trzanje mišic (mioklonus),
treptozotocin – for cancer of the pancreas cyclosporine – for changing your immune system.
treptozotocin – za zdravljenje raka slinavke; ciklosporin – spremeni delovanje imunskega sistema.
Tresiba 100 units/mL and Tresiba 200 units/mL
Zdravilo Tresiba 100 enot/ml in zdravilo Tresiba 200 enot/ml
Tresiba 100 units/mL solution for injection in cartridge
Tresiba 100 enot/ml raztopina za injiciranje v injekcijskem vložku
Tresiba 100 units/mL solution for injection in cartridge insulin degludec
Tresiba 100 enot/ml raztopina za injiciranje v injekcijskem vložku insulin degludek
Tresiba 100 units/mL solution for injection in pre-filled pen
Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku
Tresiba 100 units/mL solution for injection insulin degludec
Tresiba 100 enot/ml raztopina za injiciranje insulin degludek
Tresiba 200 units/mL solution for injection in pre-filled pen
Tresiba 200 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku
Tresiba 200 units/mL solution for injection insulin degludec
Tresiba 200 enot/ml raztopina za injiciranje insulin degludek
Tresiba can be used in adolescents and children from the age of 1 year (see section 5.1).
Zdravilo Tresiba se lahko uporablja pri mladostnikih in otrocih, starejših od 1 leta (glejte poglavje 5.1).
Tresiba can be used in elderly patients but if you are elderly you may need to check your blood sugar level more often.
Zdravilo Tresiba se lahko uporablja pri starejših bolnikih, a si morate krvni sladkor kontrolirati pogosteje.
Tresiba can be used in elderly patients.
Zdravilo Tresiba se lahko uporablja pri starejših bolnikih.
Tresiba can be used with meal-related rapid acting insulin products.
Zdravilo Tresiba se lahko uporablja tudi skupaj s hitrodelujočim insulinom, ki se ga injicira ob obroku.
Tresiba cartridge 100
Tresiba vložek 100
Tresiba comes in a cartridge (Penfill) designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist injection needles.
Zdravilo Tresiba je na voljo v injekcijskem vložku (Penfill) in je namenjeno za uporabo s sistemi za dajanje insulina Novo Nordisk in injekcijskimi iglami NovoFine ali NovoTwist.
Tresiba comes in a pre-filled pen (FlexTouch) designed to be used with NovoFine or NovoTwist injection needles.
Zdravilo Tresiba je na voljo v napolnjenem injekcijskem peresniku (FlexTouch) in je namenjeno za uporabo z injekcijskimi iglami NovoFine ali NovoTwist.
Tresiba is a basal insulin for once-daily subcutaneous administration at any time of the day, preferably at the same time every day.
Zdravilo Tresiba je bazalni insulin za subkutano uporabo enkrat na dan; aplicira se ga lahko kadar koli v teku dneva, po možnosti pa vsak dan ob istem času.
Tresiba is for subcutaneous use only.
Zdravilo Tresiba je namenjeno zgolj subkutani uporabi.
Tresiba is given as an injection under the skin (subcutaneous injection).
Zdravilo Tresiba je namenjeno injiciranju pod kožo (subkutani uporabi).
Tresiba is presented as a clear and colourless solution for injection in a cartridge (300 units per 3 mL).
Zdravilo Tresiba je na voljo kot bistra in brezbarvna raztopina za injiciranje v injekcijskem vložku (300 enot v 3 ml).
Tresiba is presented as a clear and colourless solution for injection in pre-filled pen (300 units per 3 mL).
Zdravilo Tresiba je na voljo kot bistra in brezbarvna raztopina za injiciranje v napolnjenem injekcijskem peresniku (300 enot v 3 ml).
Tresiba is presented as a clear and colourless solution for injection in pre-filled pen (600 units per 3 mL).
Zdravilo Tresiba je na voljo kot bistra in brezbarvna raztopina za injiciranje v napolnjenem injekcijskem peresniku (600 enot v 3 ml).
Tresiba is to be dosed in accordance with the individual patient’s needs.
Zdravilo Tresiba je treba odmerjati glede na potrebe posameznega bolnika.
Tresiba is to be used once-daily with meal-time insulin and requires subsequent individual dosage adjustments.
Zdravilo Tresiba je treba uporabljati enkrat na dan z insulinom ob obrokih, čemur mora slediti prilagoditev odmerjanja posamezniku.
Tresiba must not be administered intramuscularly as it may change the absorption.
Zdravila Tresiba se ne sme aplicirati intramuskularno, ker lahko povzroči spremembo v absorpciji.
Tresiba must not be used if the solution does not appear clear and colourless.
Zdravila Tresiba ne smete uporabiti, če raztopina ni bistra in brezbarvna.
Tresiba must not be used in insulin infusion pumps.
Zdravila Tresiba se ne sme uporabljati v infuzijskih črpalkah za insulin.
Tresiba pre-filled pen 100
Tresiba peresnik 100
Tresiba pre-filled pen 200
Tresiba peresnik 200
Tresiba pre-filled pen and needle (example) (FlexTouch)
napolnjen injekcijski peresnik Tresiba in igla (primer)
Tresiba which has been frozen must not be used.
Zdravila Tresiba, ki je bilo zamrznjeno, ne smete uporabiti.
Tresiba with alcohol
Zdravilo Tresiba skupaj z alkoholom
Trevaclyn (1000 mg/20 mg to 2000 mg/40 mg at week 5)
Trevaclyn (1.000 mg/20 mg do 2.000 mg/40 mg 5. teden)
Trevaclyn 1,000 mg/20 mg modified-release tablets Nicotinic acid/laropiprant
Trevaclyn 1.000 mg/20 mg tablete s prirejenim sproščanjem nikotinska kislina/laropiprant
Trevaclyn 1,000 mg/20 mg modified-release tablets.
Trevaclyn 1.000 mg/20 mg tablete s prirejenim sproščanjem
Trevaclyn 1000 mg/20 mg modified-release tablets Nicotinic acid/laropiprant
Trevaclyn 1.000 mg/20 mg tablete s prirejenim sproščanjem nikotinska kislina/laropiprant
Trevaclyn is used in addition to diet and exercise in patients with dyslipidaemia (abnormally high levels of fat in the blood), particularly ‘combined mixed dyslipidaemia’ and ‘primary hypercholesterolaemia’.
Zdravilo Trevaclyn se uporablja kot dodatek k prehrani in telesni vadbi pri bolnikih z dislipidemijo (nenormalno visoka raven maščobe v krvi), zlasti pri tistih s kombinirano mešano dislipidemijo in primarno hiperholesterolemijo.
Trevaclyn is used in addition to diet to lower your ‘bad’ cholesterol level.
Zdravilo Trevaclyn se uporablja poleg diete za: znižanje "slabega" holesterola.
Trevaclyn: No studies have been performed in paediatric patients.
Trevaclyn: Študij pri pediatričnih bolnikih niso izvedli.
Trevaclyn: Use in patients with hepatic insufficiency has not been studied.
Trevaclyn: Uporaba pri bolnikih z jetrno insuficienco ni raziskana.
TREVICTA 175 mg prolonged release suspension for injection paliperidone
TREVICTA175 mg suspenzija za injiciranje s podaljšanim sproščanjem paliperidon
TREVICTA can raise your levels of a hormone called "prolactin" found on a blood test (which may or may not cause symptoms).
Zdravilo TREVICTA lahko zviša vrednost hormona, ki ga imenujemo prolaktin, v krvnih preiskavah (kar lahko povzroči simptome ali pa ne).
TREVICTA doses for patients adequately treated with 1-monthly paliperidone palmitate injectable
Odmerki zdravila TREVICTA pri bolnikih, ki so ustrezno zdravljeni z 1-mesečnimi injekcijami paliperidonijevega palmitata
TREVICTA has not been systematically studied in patients with renal impairment (see section 5.2).
Zdravila TREVICTA niso sistematično preučevali pri bolnikih z okvaro ledvic (glejte poglavje 5.2).
TREVICTA is not recommended in patients with moderate or severe renal impairment (creatinine clearance < 50 ml/min). (See sections 4.2 and 5.2).
Uporaba zdravila TREVICTA ni priporočljiva pri bolnikih z zmerno ali hudo okvaro ledvic (z očistkom kreatinina < 50 ml/min). (Glejte poglavji 4.2 in 5.2.)
TREVICTA is to be used only after the patient has been adequately treated with 1-monthly paliperidone palmitate injectable preferably for four months or more.
Zdravilo TREVICTA se lahko uporablja samo pri bolnikih, ki so bili ustrezno zdravljeni z 1-mesečnimi injekcijami paliperidonijevega palmitata, najbolje štiri mesece ali več.
TREVICTA requires close attention to these step-by-step Instructions for Use to help ensure successful administration.
Za pravilno odmerjanje zdravila TREVICTA je potrebno natančno upoštevati vse korake, ki so opisani v navodilu.
TREVICTA should be administered once every 3 months.
Zdravilo TREVICTA je treba odmerjati enkrat na 3 mesece.
TREVICTA should be used with caution in patients with known cardiovascular disease (e.g., heart failure, myocardial infarction or ischaemia, conduction abnormalities), cerebrovascular disease, or conditions that predispose the patient to hypotension (e.g., dehydration and hypovolemia).
Pri bolnikih z znano srčnožilno boleznijo (npr. srčnim popuščanjem, miokardnim infarktom ali ishemijo, motnjami prevajanja), možganskožilno boleznijo ali stanji z zvečanim tveganjem za hipotenzijo (npr. dehidracija in hipovolemija), je treba zdravilo TREVICTA uporabljati previdno.
TREVICTA with alcohol
Zdravilo TREVICTA skupaj z alkoholom
Tri-sodium citrate dihydrate, Polysorbate 80, Mannitol, Sucrose, HCl (for pH adjustment).
Trinatrijev citrat dihidrat, polisorbat 80, manitol, saharoza, HCl (za uravnavanje pH).
Triacetin
triacetin,
triad of symptoms (meningism): neck stiffness, intolerance of bright light and headache, flu-like discomfort
kupek treh simptomov (meningizem): togost vratu, občutljivost za močno svetlobo in glavobol, neugodje, podobno kot pri gripi
Trial
Raziskava
Trial 1
1. preskušanje
Trial 1 Dyspareunia
Preskušanje 1 Disparevnija
Trial 2
2. preskušanje
Trial 2 Dyspareunia
Preskušanje 2 Disparevnija
Trial 3
3. preskušanje
Trial 3 is a Phase 3, parallel-group, multicentre, rollover study in patients with CF that includes patients from Trial 1 and Trial 2.
Preskušanje 3 je multicentrična preverjalna študija 3. faze s paralelnimi skupinami pri bolnikih s CF, ki vključuje bolnike iz preskušanja 1 in preskušanja 2.
Trial 4
4. preskušanje
Trial 4 was a multicentre, double–blind, randomised, placebo–controlled, Phase 2 trial in 125 patients with CF aged 18 years and older who had a ppFEV1 of 40 - 90, inclusive, and have the F508del mutation on one allele plus a second allele with a mutation predicted to result in the lack of CFTR production or a CFTR that is not responsive to ivacaftor in vitro.
Preskušanje 4 je bilo multicentrično, dvojno slepo, randomizirano preskušanje 2. faze, kontrolirano s placebom, pri 125 bolnikih s CF, starih 18 let ali več, ki so imeli ppFEV1 40 – 90 vključno in mutacijo F508del na enem alelu plus drugi alel z mutacijo, za katero je bilo napovedano, da bo preprečila nastajanje CFTR ali povzročila nastajanje CFTR, ki se in vitro ne odziva na ivakaftor.
Trial BP22333 (SparkThera)
Preskušanje BP22333 (SparkThera)
Trial characteristics
Značilnosti preskušanja
Trial in patients with CF who are heterozygous for the F508del mutation in the CFTR gene
Preskušanje pri bolnikih s CF, ki so heterozigotni za mutacijo F508del na genu CFTR
Trial on different vaccination schedules:
Preskušanja z različnimi reţimi cepljenja:
Trial outcome index results were supportive of FACT-L and LCS results a Values presented are for IRESSA versus carboplatin/paclitaxel.
Trial outcome index rezultati so potrdili rezultate FACT-L in LCS
Trial Week
Teden preskušanja
Trials have indicated a t½ of about 2-5 hours.
Preskušanja so pokazala t1/2 približno 2–5 urah.
Trials have indicated a t½ of about 2-5 hours.
Preskušanja so pokazala, da t1/2 znaša približno 2–5 ur.
Trials have indicated a t½ of about 5–10 hours.
Preskušanja so pokazala, da t1/2 znaša približno 5–10 ur.
Triangular tablet with mottled brown appearance embossed with the tablet strength on one side and the word “Pfizer” on the other.
Trikotna tableta lisasto rjavega videza izbočena na eni strani in označena z jakostjo tablete ter z besedo “Pfizer” na drugi.
Triangular tablet with mottled brown appearance embossed with the tablet strength on one side and the word “Pfizer” on the other.
Trikotna tableta lisasto rjavega videza izbočeno označena z jakostjo tablete na eni strani ter z besedo “Pfizer” na drugi.
Triazolam (oral)
triazolam (peroralni)
Triazolam (saquinavir/ritonavir)
parenteralno obliko midazolama, se
triazolam and midazolam (taken by mouth) - to help you sleep or for anxiety
triazolam in midazolam (ki se jemlje skozi usta) - kot pomoč pri težavah s spanjem ali tesnobi,
Triazolam and oral (taken by mouth) midazolam
triazolam in peroralni (zaužit skozi usta) midazolam
triazolam and oral (taken by mouth) midazolam (used to help you sleep and / or relieve anxiety
flekainid in propafenon (zdravila za srce).
triazolam and oral (taken by mouth) midazolam (used to help you sleep and / or relieve anxiety)
triazolam in peroralna oblika (zaužita skozi usta) midazolama (ki vam pomaga spati in/ali olajšati zaskrbljenost).
triazolam and oral (taken by mouth) midazolam (used to help you sleep and/or to relieve anxiety) simvastatin and lovastatin (used to lower blood cholesterol).
triazolam in peroralne oblike (ki se jih jemlje skozi usta) midazolama (uporabljamo jih kot pomoč pri težavah s spanjem in/ali za ublažitev tesnobe), simvastatin in lovastatin (uporabljamo ju za zniževanje holesterola v krvi).
triazolam and oral (taken by mouth) midazolam (used to help you sleep and/or to relieve anxiety).
triazolam in peroralne (ki se jih jemlje skozi usta) oblike midazolama (uporabljamo jih kot pomoč pri težavah s spanjem in/ali za ublažitev tesnobe).
Triazolam or oral midazolam taken by mouth (for anxiety or to help you sleep)
triazolam ali peroralno vzet midazolam (za tesnobo in/ali težav z nespečnostjo),
triazolam with Victrelis is
zdravilom Victrelis je
triazolam).
sedacije.
triazolam, midazolam administered orally (sedatives/hypnotics) (for caution on parenterally administered midazolam, see section 4.5) sildenafil - when used for the treatment of pulmonary arterial hypertension, avanafil (PDE-5 inhibitors) simvastatin and lovastatin (HMG-CoA reductase inhibitors) (see section 4.5) ticagrelor (antiplatelets) (see section 4.5).
triazolam, midazolam s peroralnim odmerjanjem (pomirjevala/uspavala) (za opozorila pri peroralnem odmerjanju midazolama glejte poglavje 4.5) sildenafil - kadar se uporablja za zdravljenje pljučne arterijske hipertenzije, avanafil (zaviralci fosfodiesteraze tipa 5 (PDE-5)) simvastatin in lovastatin (zaviralci reduktaze HMG-CoA) (glejte poglavje 4.5) tikagrelor (zaviralec agregacije trombocitov) (glejte poglavje 4.5)
triazolam, oral (taken by mouth) midazolam (used to help you sleep and / or relieve anxiety)
triazolam in peroralna oblika (zaužita skozi usta) midazolama (ki vam pomaga spati in/ali olajšati zaskrbljenost).
triazolam, oral midazolam and alprazolam due to potential for prolonged or increased sedation and respiratory depression
triazolam, peroralni midazolam in alprazolam zaradi potenciala za podaljšano ali povečano sedacijo ter respiratorno depresijo,
triazole antifungal agents
triazolne antimikotike
Trichuris suis (adult stages)
Trichuris suis (odrasli stadiji)
Trichuris suis (adult stages).
Trichuris suis (odrasli stadiji)
Trichuris vulpis (mature adult)
Trichuris vulpis (zrele odrasle oblike)
tricitabine/
ofovir
Tricyclic antidepressant medicines such as amitryptiline, imipramine, or monoamine oxidase inhibitors, such as phenelzine, isocarboxazide, tranylcypromine or moclobemide.
Triciklični antidepresivi, kot so amitriptilin, imipramin ali zaviralci monoaminooksidaze, kot so fenelzin, izokarboksazid, tranilcipromin ali moklobemid.
Tricyclic antidepressants (such as amitriptyline) and the antidepressant nefazodone.
triciklične antidepresive (npr. amitriptilin) in antidepresiv nefazodon.
Tricyclic antidepressants (used to treat depression).
Triciklični antidepresivi (uporabljajo se za zdravljenje depresije).
Tricyclic antidepressants (used to treat depression).
triciklični antidepresivi (uporabljajo se za zdravljenje depresije);
Triethanolamine (at doses up to 0.25 mg/kg bw) is considered not within the scope of Council Regulation (EEC) No.
Trietanolamin (v odmerkih do 0,25 mg/kg telesne mase) ni vključen v Uredbo Sveta (EGS) št.
triethyl citrate sodium lauryl sulphate Capsule shell
mukec trietilcitrat natrijev lavrilsulfat Ovojnica kapsule
Trifexis 1040 mg/17.4 mg chewable tablets for dogs (14.8 – 23.1 kg)
Trifexis 1040 mg/17,4 mg žvečljive tablete za pse (14.8 – 23.1 kg)
Trifexis 1040 mg/17.4 mg tablets: 4349 and 4 dimples
Trifexis 1040 mg/17,4 mg tablete: 4349 in 4 vdolbinice
Trifexis 1620 mg/27 mg chewable tablets for dogs (23.2 – 36.0 kg)
Trifexis 1620 mg/27 mg žvečljive tablete za pse (23.2 – 36.0 kg)
Trifexis 1620 mg/27 mg chewable tablets for dogs (23.2 – 36.0 kg) spinosad / milbemycin oxime
Trifexis 1620 mg/27 mg žvečljive tablete za pse (23.2 – 36.0 kg) spinosad/milbemicin oksim
Trifexis 1620 mg/27 mg tablets: 4336 and 5 dimples
Trifexis 1620 mg/27 mg tablete: 4336 in 5 vdolbinic
Trifexis 270 mg/4.5 mg chewable tablets for dogs (3.9 – 6.0 kg) Trifexis 425 mg/7.1 mg chewable tablets for dogs (6.1 – 9.4 kg)
Trifexis 270 mg/4,5 mg žvečljive tablete za pse (3.9 – 6.0 kg) Trifexis 425 mg/7,1 mg žvečljive tablete za pse (6.1 – 9.4 kg)
Trifexis 270 mg/4.5 mg chewable tablets for dogs (3.9 – 6.0 kg) Trifexis 425 mg/7.1 mg chewable tablets for dogs (6.1 – 9.4 kg) Trifexis 665 mg/11.1 mg chewable tablets for dogs (9.5 – 14.7 kg) Trifexis 1040 mg/17.4 mg chewable tablets for dogs (14.8 – 23.1 kg) Trifexis 1620 mg/27 mg chewable tablets for dogs (23.2 – 36.0 kg)
Trifexis 270 mg/4,5 mg žvečljive tablete za pse (3.9 – 6.0 kg) Trifexis 425 mg/7,1 mg žvečljive tablete za pse (6.1 – 9.4 kg) Trifexis 665 mg/11,1 mg žvečljive tablete za pse (9.5 – 14.7 kg) Trifexis 1040 mg/17,4 mg žvečljive tablete za pse (14.8 – 23.1 kg) Trifexis 1620 mg/27 mg žvečljive tablete za pse (23.2 – 36.0 kg)
Trifexis 270 mg/4.5 mg chewable tablets for dogs Trifexis 425 mg/7.1 mg chewable tablets for dogs Trifexis 665 mg/11.1 mg chewable tablets for dogs Trifexis 1040 mg/17.4 mg chewable tablets for dogs Trifexis 1620 mg/27 mg chewable tablets for dogs
Trifexis 270 mg/4,5 mg žvečljive tablete za pse Trifexis 425 mg/7,1 mg žvečljive tablete za pse Trifexis 665 mg/11,1 mg žvečljive tablete za pse Trifexis 1040 mg/17,4 mg žvečljive tablete za pse Trifexis 1620 mg/27 mg žvečljive tablete za pse
Trifexis 270 mg/4.5 mg for dogs (3.9 – 6.0 kg) Trifexis 425 mg/7.1 mg for dogs (6.1 – 9.4 kg) Trifexis 665 mg/11.1 mg for dogs (9.5 – 14.7 kg) Trifexis 1040 mg/17.4 mg for dogs (14.8 – 23.1 kg) Trifexis 1620 mg/27 mg for dogs (23.2 – 36.0 kg)
Trifexis 270 mg/4,5 mg za pse (3,9–6,0 kg) Trifexis 425 mg/7,1 mg za pse (6,1–9,4 kg) Trifexis 665 mg/11,1 mg za pse (9,5–14,7 kg) Trifexis 1040 mg/17,4 mg za pse (14,8–23,1 kg) Trifexis 1620 mg/27 mg za pse (23,2–36,0 kg)
Trifexis 270 mg/4.5 mg tablets: 4333 and 2 dimples
Trifexis 270 mg/4,5 mg tablete: 4333 in 2 vdolbinici
Trifexis 425 mg/7.1 mg tablets: 4346 and 3 dimples
Trifexis 425 mg/7,1 mg tablete: 4346 in 3 vdolbinice
Trifexis 425 mg/7.1 mg tablets: 4346 and 3 dimples Trifexis 665 mg/11.1 mg tablets: 4347 and no dimples
Trifexis 425 mg/7,1 mg tablete: 4346 in 3 vdolbinice Trifexis 665 mg/11,1 mg tablete: 4347 in brez vdolbinic
Trifexis 665 mg/11.1 mg chewable tablets for dogs (9.5 – 14.7 kg)
Trifexis 665 mg/11,1 mg žvečljive tablete za pse (9.5 – 14.7 kg)
Trifexis 665 mg/11.1 mg tablets: 4347 and no dimples
Trifexis 665 mg/11,1 mg tablete: 4347 in brez vdolbinic